CCL Products (India) Ltd
BSE:519600
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
552.4018
9 260
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
CCL Products (India) Ltd
CCL Products (India) Ltd
Total Current Liabilities
CCL Products (India) Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CCL Products (India) Ltd
BSE:519600
|
Total Current Liabilities
₹14.9B
|
CAGR 3-Years
53%
|
CAGR 5-Years
43%
|
CAGR 10-Years
21%
|
|
|
Tata Consumer Products Ltd
NSE:TATACONSUM
|
Total Current Liabilities
₹54.2B
|
CAGR 3-Years
29%
|
CAGR 5-Years
26%
|
CAGR 10-Years
10%
|
|
|
Britannia Industries Ltd
NSE:BRITANNIA
|
Total Current Liabilities
₹52.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
17%
|
CAGR 10-Years
16%
|
|
|
Patanjali Foods Ltd
NSE:PATANJALI
|
Total Current Liabilities
₹30.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Marico Ltd
NSE:MARICO
|
Total Current Liabilities
₹24.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Nestle India Ltd
NSE:NESTLEIND
|
Total Current Liabilities
₹37.9B
|
CAGR 3-Years
18%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
CCL Products (India) Ltd
Glance View
Nestled in the dynamic arena of the global coffee industry, CCL Products (India) Ltd. has carved a distinctive niche for itself as a leading manufacturer and exporter of instant coffee. Established in 1994, the company has transformed over the decades from a modest enterprise into a formidable entity in the coffee manufacturing sector. CCL's journey is one of relentless pursuit of quality and innovation, anchored by its state-of-the-art manufacturing facilities located in India, Vietnam, and Switzerland. These strategic locations not only enhance its manufacturing prowess but also provide a competitive advantage in global logistics and supply chain efficiencies. The company’s ability to cater to diverse consumer preferences through an expansive product range, from traditional blends to specialty and value-added variants, underscores its commitment to adaptability and customer satisfaction. CCL Products generates revenue through its extensive private label partnerships and branded offerings. It supplies instant coffee to more than 90 countries, crafting unique blends to suit the tastes of varied markets. The company's business model is not restricted to the mere production of coffee; it weaves in an intricate tapestry of strategic partnerships with retailers and beverage companies, enabling it to stay attuned to the evolving dynamics of the global coffee market. By integrating cutting-edge technology and maintaining stringent quality controls, CCL ensures its products meet international standards, while also leveraging cost-effective production methods. This balance of innovation, efficiency, and responsiveness forms the cornerstone of CCL Products’ business strategy, allowing it to sustain profitability and foster long-term growth in an ever-competitive landscape.
See Also
What is CCL Products (India) Ltd's Total Current Liabilities?
Total Current Liabilities
14.9B
INR
Based on the financial report for Sep 30, 2024, CCL Products (India) Ltd's Total Current Liabilities amounts to 14.9B INR.
What is CCL Products (India) Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
21%
Over the last year, the Total Current Liabilities growth was 48%. The average annual Total Current Liabilities growth rates for CCL Products (India) Ltd have been 53% over the past three years , 43% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet